tiprankstipranks
Trending News
More News >
Hikma Pharmaceuticals PLC (HKMPY)
OTHER OTC:HKMPY
US Market

Hikma Pharmaceuticals (HKMPY) Financial Statements

Compare
45 Followers

Hikma Pharmaceuticals Financial Overview

Hikma Pharmaceuticals's market cap is currently $4.65B. The company's EPS TTM is $2.168; its P/E ratio is 12.52; and it has a dividend yield of 4.04%. Hikma Pharmaceuticals is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 3.13B$ 2.88B$ 2.52B$ 2.55B$ 2.34B
Gross Profit$ 1.42B$ 1.41B$ 1.24B$ 1.30B$ 1.20B
Operating Income$ 612.00M$ 367.00M$ 282.00M$ 582.00M$ 579.00M
EBITDA$ 727.00M$ 559.00M$ 688.00M$ 766.00M$ 747.00M
Net Income$ 359.00M$ 190.00M$ 188.00M$ 421.00M$ 431.00M
Balance Sheet
Cash & Short-Term Investments$ 213.00M$ 229.00M$ 292.00M$ 450.00M$ 347.00M
Total Assets$ 5.13B$ 4.68B$ 4.47B$ 4.37B$ 4.13B
Total Debt$ 1.31B$ 1.19B$ 1.28B$ 846.00M$ 932.00M
Net Debt$ 1.12B$ 986.00M$ 1.01B$ 420.00M$ 609.00M
Total Liabilities$ 2.81B$ 2.47B$ 2.32B$ 1.91B$ 1.99B
Stockholders' Equity$ 2.31B$ 2.20B$ 2.13B$ 2.45B$ 2.13B
Cash Flow
Free Cash Flow$ 329.00M$ 404.00M$ 305.00M$ 409.00M$ 240.00M
Operating Cash Flow$ 564.00M$ 608.00M$ 530.00M$ 638.00M$ 464.00M
Investing Cash Flow$ -381.00M$ -333.00M$ -607.00M$ -238.00M$ -283.00M
Financing Cash Flow$ -188.00M$ -337.00M$ -58.00M$ -287.00M$ -298.00M
Currency in USD

Hikma Pharmaceuticals Earnings and Revenue History

Hikma Pharmaceuticals Debt to Assets

Hikma Pharmaceuticals Cash Flow

Hikma Pharmaceuticals Forecast EPS vs Actual EPS